Primary |
Drug Use For Unknown Indication |
37.6% |
Product Used For Unknown Indication |
17.9% |
Blood Triglycerides Increased |
10.5% |
Blood Cholesterol Increased |
9.1% |
Hypertension |
7.7% |
Diabetes Mellitus |
2.9% |
Hyperlipidaemia |
1.8% |
Dyslipidaemia |
1.4% |
Blood Cholesterol |
1.4% |
Gastrooesophageal Reflux Disease |
1.1% |
Vitamin Supplementation |
1.1% |
Hypothyroidism |
1.1% |
Hypertriglyceridaemia |
1.0% |
High Density Lipoprotein Decreased |
1.0% |
Depression |
1.0% |
Cardiac Disorder |
0.7% |
Pain |
0.7% |
Anxiety |
0.6% |
Low Density Lipoprotein Increased |
0.6% |
Prophylaxis |
0.6% |
|
Myalgia |
13.7% |
Blood Creatinine Increased |
10.8% |
Rash |
10.6% |
Blood Triglycerides Increased |
7.8% |
Nausea |
6.2% |
Hepatic Enzyme Increased |
5.2% |
High Density Lipoprotein Decreased |
4.7% |
Pain In Extremity |
4.5% |
Headache |
3.9% |
Rhabdomyolysis |
3.9% |
Pancreatitis |
3.5% |
Drug Ineffective |
3.4% |
Liver Function Test Abnormal |
3.1% |
Muscle Spasms |
3.1% |
Urticaria |
3.0% |
Low Density Lipoprotein Increased |
2.8% |
Renal Impairment |
2.8% |
Vomiting |
2.5% |
Pruritus |
2.4% |
Glomerular Filtration Rate Decreased |
2.3% |
|
Secondary |
Drug Use For Unknown Indication |
21.2% |
Product Used For Unknown Indication |
20.8% |
Blood Triglycerides Increased |
12.9% |
Blood Cholesterol Increased |
12.2% |
Hypertension |
7.1% |
High Density Lipoprotein Decreased |
4.4% |
Diabetes Mellitus |
3.2% |
Prophylaxis |
2.8% |
Low Density Lipoprotein Increased |
2.1% |
Hypersensitivity |
1.7% |
Dyslipidaemia |
1.6% |
Hyperlipidaemia |
1.6% |
Hypertriglyceridaemia |
1.6% |
Blood Cholesterol |
1.4% |
Depression |
1.2% |
Breast Cancer |
1.0% |
Gastrooesophageal Reflux Disease |
1.0% |
Pain |
0.9% |
Vitamin Supplementation |
0.8% |
Blood Cholesterol Abnormal |
0.7% |
|
Myalgia |
14.6% |
Muscle Spasms |
9.5% |
Nausea |
7.0% |
Rash |
7.0% |
Blood Triglycerides Increased |
6.0% |
Drug Ineffective |
5.0% |
Blood Creatinine Increased |
4.5% |
Low Density Lipoprotein Increased |
4.5% |
Vomiting |
4.5% |
Pain In Extremity |
4.0% |
Urticaria |
4.0% |
Chest Pain |
3.5% |
High Density Lipoprotein Decreased |
3.5% |
Pain |
3.5% |
Rhabdomyolysis |
3.5% |
Blood Glucose Increased |
3.0% |
Drug Hypersensitivity |
3.0% |
Headache |
3.0% |
Pollakiuria |
3.0% |
Renal Impairment |
3.0% |
|
Concomitant |
Product Used For Unknown Indication |
53.5% |
Drug Use For Unknown Indication |
7.9% |
Blood Cholesterol Increased |
6.9% |
Hypertension |
4.5% |
Blood Triglycerides Increased |
4.3% |
Diabetes Mellitus |
2.7% |
High Density Lipoprotein Decreased |
2.1% |
Gastrooesophageal Reflux Disease |
1.9% |
Type 2 Diabetes Mellitus |
1.7% |
Blood Cholesterol |
1.7% |
Depression |
1.6% |
Pain |
1.5% |
Hyperlipidaemia |
1.4% |
Vitamin Supplementation |
1.3% |
Psoriasis |
1.2% |
Crohn's Disease |
1.2% |
Low Density Lipoprotein Increased |
1.2% |
Atrial Fibrillation |
1.1% |
Blood Pressure |
1.1% |
Cardiac Disorder |
1.1% |
|
Flushing |
29.8% |
Pruritus |
12.2% |
Paraesthesia |
5.8% |
Skin Burning Sensation |
4.9% |
Blood Glucose Increased |
4.7% |
Feeling Hot |
4.6% |
Myalgia |
4.4% |
Vomiting |
3.9% |
Rash |
3.0% |
Weight Decreased |
3.0% |
Weight Increased |
3.0% |
Headache |
2.9% |
Pancreatitis Acute |
2.9% |
Nausea |
2.4% |
Pain In Extremity |
2.2% |
Pancreatitis |
2.2% |
Dyspnoea |
2.0% |
Fatigue |
2.0% |
Oedema Peripheral |
2.0% |
Pain |
2.0% |
|